Doxepin hydrochloride is one of a class of psychotherapeutic agents known as dibenzoxepin tricyclic compounds. Doxepin is recommended for the treatment of psychoneurotic patients with depression and/or anxiety.

We provide a separate index of clinical trials research involving drugs used in mental health. You can search directly or browse by condition, sponsor, or clinical trial status.

Effexor (venlafaxine hydrochloride) is indicated for the treatment of major depressive disorder. The efficacy of Effexor (venlafaxine hydrochloride) as a treatment for major depressive disorder was established in 5 placebo-controlled, short-term trials.

Emsam (selegiline transdermal system) is a transdermally administered antidepressant. When applied to intact skin, Emsam is designed to continuously deliver selegiline over a 24-hour period. Emsam is indicated for the treatment of major depressive disorder.

Fanapt^® tablets are indicated for the treatment of adults with schizophrenia. The effectiveness of FANAPT in long-term use, that is, for more than 6 weeks, has not been systematically evaluated in controlled trials.

Fentanyl transdermal system is indicated for management of persistent, moderate to severe chronic pain that requires continuous, around-the-clock opioid administration for an extended period of time, and cannot be managed by other means.

Butalbital (5-allyl-5-isobutylbarbituric acid), is a short to intermediate-acting barbiturate. Fioricet (Butalbital, Acetaminophen, and Caffeine Tablets, USP) is indicated for the relief of the symptom complex of tension (or muscle contraction) headache.